Brief introduction：First generics and exclusive in Chinese market; indicated in adults and pediatric patients 6 months and older for the: 1. Management of mild to moderate pain and the management of moderate to severe pain as an adjunct to opioid analgesics 2. Reduction of fever
By law of People's Republic of China, no publishment is allowed for psychotropic drugs.
Add:No.8, Xiyuan Ave., Hi-tech District, Chengdu, 611731, China
Qingmu Pharmaceutical (API site)
Add: No.55, South Shunjiang Avenue, East Economic Development Zone, Meishan City, Sichuan, 612100, China
API Sales: +86-28-87827187
Add: No.8, Xiyuan Ave., Hi-tech District, Chengdu, 611731, China
This website does not publish the product information of narcotic drugs, psychotropic drugs, toxic drugs for medical use, radioactive drugs, drug rehabilitation drugs and preparations of medical institutions.|